Skip to content

Diart 1, 1% 2 ml

by Diaco Biofarmaceutici srl 2 variants

Ref 6094Model EasyGo

Active European Union

CE MDR

Valid until

11 Feb 2031

CE MDR certificate

FDA recalls

Not applicable

No FDA record for this device

Documents

2 certificates

Certifier ISTITUTO SUPERIORE DI SANITA'

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 24 Oct 2026. What this means

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number805902020FILLERHC4 Basic UDI-DI 08059020201456UDI-DIDate27 Feb 2026RegisteredStatusActive

Certificates

2 certificates · EUDAMED

EUDAMED certificates (2)
  • CSQ0033260126 Active Supplemented

    Quality management system EU MDR

    Issued
    12 Feb 2026
    Expires
    11 Feb 2031
    Reason
    Add device or group
  • CVD005326 Active

    Technical documentation EU MDR

    Issued
    12 Feb 2026
    Expires
    11 Feb 2031

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device Name
Diart
Model / Reference
EasyGo, 6094
Primary DI / UDI-DI
08059020201456
Basic UDI-DI
805902020FILLERHC4
EMDN Code
P900402 Resorbable filling and reconstruction devices
Device Class
Class III
EU market of registration
Italy

Manufacturer details

EUDAMED SRN
IT-MF-000012117

Other devices from Diaco Biofarmaceutici srl

See all devices from Diaco Biofarmaceutici srl →

Properties

  • Sterile
  • Implantable

Other properties (11)

  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No